Retiro De Equipo O Alerta De Seguridad para Products for endovascular surgery: high pressure syringe Everest 20 atm. (batch number 50755851)

Según Ministry of Health of the Republic of Belarus, este evento ( retiro de equipo o alerta de seguridad ) involucró a un dispositivo médico en Belarus que fue producido por Medtronic Inc. (plant - Medtronic Vascular), USA Medtronic Inc. (plant - Medtronic Mexico in Mexico), USA.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall / Safety alert
  • Número del evento
    ИМ-7.96332, ИМ-7.96335
  • Fecha
    2014-02-26
  • País del evento
  • Fuente del evento
    MHRB
  • URL de la fuente del evento
  • Notas / Alertas
    Belarussian data is current through June 2016. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Belarus.
  • Notas adicionales en la data
  • Causa
    In connection with the incorrect labeling of the product, the manufacturer sent letters to all consumers about the events to be carried out when using the specified batch of high-pressure syringes everest 20 atm. (batch number 50755851), and the need to contact your medtronic distributor. the number of sold products was 191 pcs. according to the data in the letter to medtronic, the products were sold in the united states in 6 states: texas, maine, iowa, pennsylvania, oregon and new hampshire.

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    MHRB